Ask AI
Test Your Skills: Biomarkers in NSCLC
Test Your Skills: The Importance of Biomarker Testing for Patients With Advanced NSCLC

Released: September 16, 2024

Activity

Progress
1 2
Course Completed

Follow-up—Case Continued
The results from the comprehensive DNA-based NGS using the existing tumor tissue showed 1 variant of unknown significance (VUS) detected in the report: ALK T25S.

Based on the results of the DNA-based tissue testing, what do you recommend next for this patient?